Endothelial growth factors and their receptors may provide important therap
eutic tools for the treatment of pathological conditions characterised by d
efective or aberrant angiogenesis. Vascular endothelial growth factor (VEGF
) is pivotal for vasculogenesis and for angiogenesis in normal and patholog
ical conditions. VEGF-B and VEGF-C provide this gene family with additional
functions, for example, VEGF-C also regulates lymphangiogenesis.